(Q38825543)

6 September 2017

title

Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model (English)

1 reference

6 September 2017

0 references

1 reference

Jaime Henrique Amorim

object named as

Jaime Henrique Amorim

1

0 references

Camila M Romano

8

object named as

Camila Malta Romano

1 reference

6 September 2017

author name string

Rúbens Prince dos Santos Alves

2

1 reference

6 September 2017

Raíza Bizerra

3

1 reference

6 September 2017

Sara Araújo Pereira

4

1 reference

6 September 2017

Lennon Ramos Pereira

5

1 reference

6 September 2017

Denicar Lina Nascimento Fabris

6

1 reference

6 September 2017

Robert Andreata Santos

7

1 reference

6 September 2017

Luís Carlos de Souza Ferreira

9

1 reference

6 September 2017

language of work or name

English

0 references

publication date

20 October 2015

1 reference

6 September 2017

1 reference

6 September 2017

volume

487

1 reference

6 September 2017

page(s)

41-49

1 reference

A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

The global distribution and burden of dengue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Microglia: Intrinsic immuneffector cell of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Development of Sanofi Pasteur tetravalent dengue vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Dengue: a continuing global threat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

The Roles and Perspectives of Toll-Like Receptors and CD4(+) Helper T Cell Subsets in Acute Viral Encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

WHO dengue case classification 2009 and its usefulness in practice: an expert consensus in the Americas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

A fusogenic peptide expressed on the surface of Salmonella enterica elicits CTL responses to a dengue virus epitope.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Capturing a virus while it catches its breath

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Virus-specific T lymphocytes home to the skin during natural dengue infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Inter- and intra-host viral diversity in a large seasonal DENV2 outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Research on dengue during World War II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

The structural basis for serotype-specific neutralization of dengue virus by a human antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Prospects for a dengue virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Dynamics of cellular immune responses in the acute phase of dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

Role of humoral versus cellular responses induced by a protective dengue vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.10.006

10.1016/J.VIROL.2015.10.006

7 January 2021

Identifiers

DOI

1 reference

release_sgn3uztav5a3jhrv2qjtsg3xja

6 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sgn3uztav5a3jhrv2qjtsg3xja

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference